72205-026-01 : NDC 2026 Code

72205-026-01 : Fosaprepitant ( Fosaprepitant )

Additionally :

You can get information about “72205-026-01” NDC code in 72205-026-01 in HTML format

HTML | 72205-026-01 in TXT (Plain Text) format

TXT | 72205-026-01 in PDF (Portable Document Format)

PDF | 72205-026-01 in XML format

XML formats.

NDC Code : 72205-026-01 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "72205-026-01",
    "PackageDescription": "1 VIAL, SINGLE-DOSE in 1 CARTON (72205-026-01)  / 5 mL in 1 VIAL, SINGLE-DOSE",
    "NDC11Code": "72205-0026-01",
    "ProductNDC": "72205-026",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Fosaprepitant",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Fosaprepitant",
    "DosageFormName": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20190905",
    "EndMarketingDate": "20250115",
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA209965",
    "LabelerName": "Novadoz Pharmaceuticals LLC",
    "SubstanceName": "FOSAPREPITANT DIMEGLUMINE",
    "StrengthNumber": "150",
    "StrengthUnit": "mg/5mL",
    "Pharm_Classes": "Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2025-01-16",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": null,
    "StartMarketingDatePackage": "20190905",
    "EndMarketingDatePackage": "20250115",
    "SamplePackage": "N"
  }
}